About PharmaCann
PharmaCann is a Consumer company based in Oak Park (United States) founded in 2014, and was acquired by MedMen in October 2018. Cannabis is cultivated, processed, and retailed by PharmaCann vertically. PharmaCann has raised $218.7 million across 14 funding rounds from investors including MedMen, XS Financial and The Cronos Group. The company has 979 employees. PharmaCann has completed 1 acquisition, including LivWell. Its chief executive, as recorded, is Brett Novey. Its website pharmacann.com draws about 13 thousand monthly visits. Its focus areas include Healthcare and Cannabis Services.
Company details
PharmaCann was founded in 2014 in Oak Park, United States, as a vertically integrated cannabis company. Cannabis is cultivated and processed into various products, which are then distributed through company-owned retail dispensaries. A range of cannabis products is provided to address diverse consumer needs. The full supply chain, from seed to sale, is managed within operations focused on the cannabis sector.
- Headquarters Oak Park, United States
- Employees 979
- Stage Acquired
- SectorsConsumer
- Phone•••• ••••
- Website pharmacann.com
- Acquired by MedMen (Oct 2018)
Funding Insights of PharmaCann
PharmaCann has successfully raised a total of $218.7M across 14 strategic funding rounds. The most recent funding activity was a Series D round of $35 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $218.7M
- Total Rounds 14
- Last Round Series D — $35M
- First Round $20M
(Sep 2014)
- Investors Count 2
Latest 10 of 14 funding rounds of PharmaCann with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2024 | $35M | Series D | – | – | – |
| Nov 2023 | $10M | Series C | – | – | – |
| Apr 2023 | $9M | Series C | – | – | – |
| Oct 2022 | $2.2M | Series C | – | – | – |
| Jun 2022 | $25M | Debt – Conventional | – | – | – |
| Jun 2021 | $85M | Debt – Conventional | – | – | – |
| Mar 2021 | $31.85M | Series C | – | The Cronos Group | – |
| Sep 2020 | $35.94M | Series B | – | – | – |
| May 2020 | $4.9M | Debt – Conventional | – | – | |
| Feb 2020 | $27.73M | Series B | – | – | – |
3 investors in total: 3 institutional.
Investors in PharmaCann
PharmaCann has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include MedMen, XS Financial and The Cronos Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Medicinal cannabis products are produced and supplied by the company. | 2013 | thecronosgroup.com | Toronto, Canada | |
Equipment leasing solutions are provided for cannabis and hemp sectors. | 2017 | xsfinancial.com | Los Angeles, United States | |
Comprehensive management and consulting services for marijuana operations are provided. | 2010 | medmen.com | Culver City, United States |
Investor details for PharmaCann
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PharmaCann
68 people are tracked at PharmaCann (24 in leadership, 44 in team); the tracked headcount is 979.
| Name | Role | Group |
|---|---|---|
Brett Novey | CEO | Leadership |
Stephanie Kiley | Director Of Merchandising Operations | Leadership |
Andrew Lopez | Director Talent Acquisition | Leadership |
Rebecca Redondo | Director Of Demand Planning | Leadership |
Jacob Lewis | Director Of Asset Protection | Leadership |
Jamie Apperson | Director Of Sales - Pa/ma/md | Leadership |
David Chiovetti | Chief Commercial Officer (cco) | Leadership |
Patrick Unzicker | Chief Financial Officer | Leadership |
Kelly Meyer | VP Retail | Leadership |
Robert McQueen | Chief Legal Officer | Leadership |
Daniel Roth | Chief Accounting Officer | Leadership |
Chris Diorio Rph. | Director Of Research And Development | Leadership |
Greg Fodell | Chief Investment Officer | Leadership |
Maryalyce Saenz | Vice President Of Merchandising | Leadership |
Franklin Ravelo | Regional Sales Director | Leadership |
Thom Maytas | General Manager | Leadership |
Alexia Garza | General Manager | Leadership |
Jennifer Kelley | Director National Sales Operations | Leadership |
Tahira Bailey | General Manager | Leadership |
Chantal L. | General Manager | Leadership |
48 more people are available in the full profile.
Complete people profiles for PharmaCann
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharmaCann
PharmaCann has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include LivWell.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cannabis products, apparel, and accessories are distributed by LivWell. | livwell.com | Colorado Springs, United States | 2009 | Oct 2021 | •••• |
Complete acquisition details for PharmaCann
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PharmaCann
Web traffic of PharmaCann
The website of PharmaCann (pharmacann.com) receives about 12.9K visits a month.
- Monthly visits12.9K
▼ 20.3% vs previous month
Websites whose visitors overlap most with PharmaCann. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| newcannabisventures.com | 100% | 14K | #1,921,652 | View details |
Top companies in Cannabis Platforms & Ecosystem Services
3 companies that operate in the same segment as PharmaCann (Cannabis Platforms & Ecosystem Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Legal medical and recreational cannabis products are manufactured. | 2016 | Ann Arbor, Michigan, United States | USD 89.95 M | 214 | ||
Consumer lawn and garden products and services are provided. | 1868 | Columbus, Ohio, United States | USD 3.41 B | 5,300 | ||
Provider of cannabis dispensaries, cultivators, CPG brands, and services | Denver, Colorado, United States | USD 172.45 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PharmaCann
PharmaCann was founded in 2014.
PharmaCann is headquartered in Oak Park, United States. It is registered at Oak Park, Illinois, United States.
Brett Novey is the CEO of PharmaCann, as recorded in our data.
PharmaCann is a funded company, having raised a total of $218.7M across 14 funding rounds to date. The company's 1st funding round was a Series B of $27.73M, raised on Sep 2014.
PharmaCann has 979 employees.
PharmaCann was founded in 2014 in Oak Park, United States, as a vertically integrated cannabis company. Cannabis is cultivated and processed into various products, which are then distributed through company-owned retail dispensaries. A range of cannabis products is provided to address diverse consumer needs. The full supply chain, from seed to sale, is managed within operations focused on the cannabis sector.
PharmaCann has made 1 acquisition, including LivWell.
PharmaCann has 3 investors. Key investors include MedMen, XS Financial, and The Cronos Group.
Yes. PharmaCann was acquired by MedMen in October 2018.